Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Receivables (2019 - 2025)

Historic Receivables for Volitionrx (VNRX) over the last 8 years, with Q3 2025 value amounting to $309085.0.

  • Volitionrx's Receivables fell 112.79% to $309085.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $309085.0, marking a year-over-year decrease of 112.79%. This contributed to the annual value of $110574.0 for FY2024, which is N/A changed from last year.
  • Latest data reveals that Volitionrx reported Receivables of $309085.0 as of Q3 2025, which was down 112.79% from $189597.0 recorded in Q2 2025.
  • Volitionrx's 5-year Receivables high stood at $312611.0 for Q3 2024, and its period low was $5492.0 during Q3 2022.
  • Moreover, its 5-year median value for Receivables was $91591.5 (2022), whereas its average is $110004.8.
  • Per our database at Business Quant, Volitionrx's Receivables surged by 578347.11% in 2021 and then plummeted by 7193.09% in 2022.
  • Volitionrx's Receivables (Quarter) stood at $12510.0 in 2021, then surged by 480.41% to $72609.0 in 2022, then crashed by 52.57% to $34441.0 in 2023, then soared by 221.05% to $110574.0 in 2024, then soared by 179.53% to $309085.0 in 2025.
  • Its Receivables was $309085.0 in Q3 2025, compared to $189597.0 in Q2 2025 and $187830.0 in Q1 2025.